138 related articles for article (PubMed ID: 1585286)
1. Examinations of the relative fluidity in cerebrovascular disease patients.
Szobor A; Klein M
Ther Hung; 1992; 40(1):8-11. PubMed ID: 1585286
[TBL] [Abstract][Full Text] [Related]
2. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
[TBL] [Abstract][Full Text] [Related]
3. [Effect of vinpocetin on the hemorheologic parameters in patients with chronic cerebrovascular disease].
Szapáry L; Horváth B; Alexy T; Márton Z; Késmárky G; Szóts M; Nagy F; Czopf J; Tóth K
Orv Hetil; 2003 May; 144(20):973-8. PubMed ID: 12830727
[TBL] [Abstract][Full Text] [Related]
4. Effect of vinpocetine on red blood cell deformability in stroke patients.
Hayakawa M
Arzneimittelforschung; 1992 Apr; 42(4):425-7. PubMed ID: 1642666
[TBL] [Abstract][Full Text] [Related]
5. Effects of TCV-3B (vinpocetine) on blood viscosity in ischemic cerebrovascular diseases.
Osawa M; Maruyama S
Ther Hung; 1985; 33(1):7-12. PubMed ID: 3842000
[No Abstract] [Full Text] [Related]
6. The effect of vinpocetine on cerebral blood flow in patients with cerebrovascular disorders.
Tamaki N; Kusunoki T; Matsumoto S
Ther Hung; 1985; 33(1):13-21. PubMed ID: 3841996
[No Abstract] [Full Text] [Related]
7. Pentoxifylline attenuates the increase in whole blood viscosity after transfusion.
Bacher A; Eggensperger E; Koppensteiner R; Mayer N; Klimscha W
Acta Anaesthesiol Scand; 2005 Jan; 49(1):41-6. PubMed ID: 15675980
[TBL] [Abstract][Full Text] [Related]
8. Open-labeled phase III clinical trials with vinpocetine in Japan.
Ebi O
Ther Hung; 1985; 33(1):41-9. PubMed ID: 3915913
[No Abstract] [Full Text] [Related]
9. [Agents to improve cerebrovascular circulation and cerebral metabolism--vinpocetine].
Tamaki N; Matsumoto S
Nihon Rinsho; 1985 Feb; 43(2):376-8. PubMed ID: 2987571
[No Abstract] [Full Text] [Related]
10. [A differential approach to cavinton and finoptin treatment of patients with circulatory encephalopathies].
Burtsev EM; Shprakh VV; Savkov VS
Ross Med Zh; 1992; (2):41-3. PubMed ID: 1643337
[No Abstract] [Full Text] [Related]
11. Hemorheologic conditions in patients with cerebrovascular disease altered by treatment with pentoxifylline.
Ott E; Lechner H
Ric Clin Lab; 1981; 11 Suppl 1():253-6. PubMed ID: 7188113
[TBL] [Abstract][Full Text] [Related]
12. In vitro antioxidant properties of pentoxifylline and vinpocetine in a rheological model.
Horvath B; Vekasi J; Kesmarky G; Toth K
Clin Hemorheol Microcirc; 2008; 40(2):165-6. PubMed ID: 19029641
[No Abstract] [Full Text] [Related]
13. [The role of vinpocetine in the treatment of cerebrovascular diseases based in human studies].
Bagoly E; Fehér G; Szapáry L
Orv Hetil; 2007 Jul; 148(29):1353-8. PubMed ID: 17631470
[TBL] [Abstract][Full Text] [Related]
14. [Effect of cavinton on the hemorheological parameters of chronic cerebrovascular patients].
Sapary L; Horvath B; Alexy T; Marton Z; Kesmarky G; Zsots M; Nagy F; Czopf I; Toth K
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(6):47-51. PubMed ID: 16841484
[No Abstract] [Full Text] [Related]
15. Vinpocetine and pyritinol: a new model for blood rheological modulation in cerebrovascular disorders—a randomized controlled clinical study.
Alkuraishy HM; Al-Gareeb AI; Albuhadilly AK
Biomed Res Int; 2014; 2014():324307. PubMed ID: 25548768
[TBL] [Abstract][Full Text] [Related]
16. Macro- and microrheological parameters of blood in patients with cerebral and peripheral atherosclerosis: the molecular change mechanisms after pentoxifylline treatment.
Muravyov AV; Bulaeva SV; Tikhomirova IA; Zamishlayev AV; Uzikova EV; Miloradov MJ
Clin Hemorheol Microcirc; 2011; 49(1-4):431-9. PubMed ID: 22214714
[TBL] [Abstract][Full Text] [Related]
17. The effect of a cerebral vasodilator, vinpocetine, on cerebral vascular resistance evaluated by the Doppler ultrasonic technique in patients with cerebrovascular diseases.
Miyazaki M
Angiology; 1995 Jan; 46(1):53-8. PubMed ID: 7818157
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of vinpocetine, pentoxifylline and nicergoline on red blood cell deformability.
Hayakawa M
Arzneimittelforschung; 1992 Feb; 42(2):108-10. PubMed ID: 1610415
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic approach to TIA and acute cerebral stroke in geriatric patients using a platelet aggregation inhibiting and vasoactive drug].
Cucinotta D; Monica C; Silvestrini C; Ceccato S; Cocchi C
G Clin Med; 1979 Apr; 60(4):301-9. PubMed ID: 488589
[No Abstract] [Full Text] [Related]
20. [Effect of cavinton on systemic and cerebral hemodynamics of patients with chronic cerebral circulatory insufficiency].
Ishchenko MM; Shkrobot SI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1338-42. PubMed ID: 4072532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
